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Résumé 
Introduction: L'administration aiguë d'insuline induit des effets cardio-vasculaires par la libération 
de monoxide d'azote (NO) et la stimulation de l'activité nerveuse sympathique. Cependant, il n'est 
pas encore établi si la stimulation du flux vasculaire musculaire (et la libération de NO) est le 
résultat d'une action directe de l'insuline au niveau des vaisseaux sanguins et/ou de la stimulation de 
mécanismes nerveux vasodilatateurs. 
Méthode Nous avons étudié 9 patients ayant subi une sympathectomie thoracique pour une 
hyperhydrose, afin d'examiner les effets vasculaires de l'insuline en présence ou en absence de 
l'innervation sympathique vasoconstrictrice et vasodilatatrice. 
Résultats: Pendant un clamp euglycémique de 2 heures, l'administration d'insuline (6 pmol/kg/min) 
induit une augmentation du flux musculaire d'environ le 40% tant dans le membre innervé que dans 
le membre dénervé (p<0.01 vs valeur basale pour les deux membres). Cette vasodilatation atteint 
son maximum dans les 30 à 45 premières minutes du clamp dans le membre dépourvu d'innervation 
sympathique(bras). Par contre, la vasodilatation maximale dans le membre normalement innervé 
Gambe) est seulement atteinte 2 heures après le début du clamp (p<0.01, membre dénervé vs 
membre innervé). 
L'administration parentérale d'un inhibiteur de la NO synthase (L-NMMA, 50 µg/kg/min), 
provoque une augmentation de la pression artérielle basale, abolit la vasodilatation induite par 
l'insuline dans le membre dénervé et induit une augmentation significative de la pression artérielle 
durant le clamp hyperinsulinémique euglycémique. Par contre, l'inhibition de la NO synthase ne 
modifie pas la sensibilité métabolique globale à l'insuline. 
Conclusions: Ces données indiquent que, dans un membre dépourvu d'innervation sympathique, 
l'insuline provoque une vasodilatation par une action directe au niveau vasculaire. Cet effet est 
médié par la libération de monoxide d'azote et semblerait être masqué par le tonus sympathique 
vasoconstricteur dans un membre normalement innervé. 
Eff ects of Sympathectomy and Ni tric Oxide Synthase 
Inhibition on Vascular Actions of Insulin in Humans 
Claudio Sartori, Lionel Trueb, Pascal Nicod, Urs Scherrer 
Abstract-Insulin exerts cardiovascular actions by stimulating nitric oxide (NO) release and sympathetic neural outflow. 
It is unclear, however, whether insulin stimulates muscle blood flow (and NO release) by a direct action at the 
vasculature and/or by stimulating neural vasodilator mechanisms. In these studies we used patients with regional 
sympathectomy to examine the vascular actions of insulin in the presence and absence of sympathetic vasoconstrictor 
and vasodilator innervation. A 2-hour insulin (6 pmol/kg per minute)/glucose clamp increased muscle blood flow in both 
innervated and denervated limbs by roughly 40% (P<0.01 versus baseline for both limbs). The vasodilation reached its 
maximum within the first 30 to 45 minutes of insulin/glucose infusion in sympathetically denervated limbs, but only at 
the end of the infusion in innervated limbs (P<0.01, denervated versus innervated limb). Infusion of a NO synthase 
inhibitor (N°-monomethyl-L-arginine [L-NMMA]) increased baseline arterial pressure, abolished the vasodilation in the 
denervated limb, and led to a significant additional increase in arterial pressure during the clamp, but did not alter whole 
body glucose uptake. Our data indicate that insulin stimulates blood flow in sympathectomized limbs by a direct action 
at the vasculature. This effect is mediated by stimulation of NO release and appears to be masked by the sympathetic 
vasoconstrictor tone in innervated limbs. (Hypertension. 1999;34:586-589.) 
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T here is now abundant evidence that insulin exerts car-diovascular actions that are mediated at least in part by 
the sympathetic nervous system and the L-arginine nitric 
oxide (NO) system.1 In lean, healthy subjects, insulin infusion 
increases both sympathetic neural outflow and blood flow in 
skeletal muscle tissue.2 The latter is caused by stimulation of 
NO synthesis since it is abolished by intra-arterial _N<'-mono-
methyl-L-arginine (L-NMMA) infusion.3•4 Despite much re-
search in the field, it is not clear however, whether insulin 
stimulates muscle blood flow (and NO release) by a direct 
action at the vasculature and/or by stimulating neural vaso-
dilator mechanisms. 1 Specifically, studies using local, intra-
arterial insulin infusion to probe whether insulin bas a direct 
vasodilator action have produced conflicting results. 1 
To examine the role played by neural versus local vasodi-
lator mechanisms and their interplay with neural vasocon-
strictor mechanisms, we compared, in lean subjects who had 
undergone regional sympathectomy for hyperhidrosis, the 
vasodilator responses to insulin infusion in the sympatheti-
cally denervated and innervated limb. To gain additional 
insight into underlying mechanisms, we studied effects of NO 
synthase inhibition on vascular responses to insulin infusion 
in the denervated limb. 
Methods 
Nine lean, healthy subjects (5 men and 4 women; body mass index, 
22.5±1.2 kg/m2 ; mean±SE age, 34±4 years) who had undergone 
regional thoracic sympathectomy for hyperhidrosis participated in 
this study after providing informed written consent. All subjects 
were normotensive, were taking no medication, and had no evidence 
of metabolic or cardiovascular disease at the time of the study. Tests 
were all conducted in the moming after an ovemight fast. Subjects 
had been on a weight-maintaining diet containing at least 40% 
energy as carbohydrates for 3 days before the tests. The experimental 
protocol was approved by the Institutional Review Board on 
Human Investigation. 
General Procedures 
Subjects were studied in the supine position. Heart rate (ECO), 
respiratory excursions (Pneumobelt), blood pressure (Finapres blood 
pressure monitor, Ohmeda),5 and limb blood flow (verrous occlusion 
plethysmography) were recorded continuously on an electrostatic 
recorder. Intravenous catheters were inserted in a right and left 
antecubital vein, one for substrate and drug infusion and the other for 
blood sampling. 
Measurement of Muscle Blood Flow 
Blood flow in an ipsilateral forearm and calf was measured with 
verrous occlusion plethysmography, with the use of mercury-in-
silastic strain gauges.5 Both limbs were elevated 10 to 15 cm above 
the level of the right atrium to collapse the veins. The circulation to 
the hand and the foot was arrested by inflating a cuff around the wrist 
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and the ankle to suprasystolic pressure during blood flow 
determinations. 
Experimental Protocols 
Protocol 1: Hyperinsulinemic Euglycemic Clamp Alone 
After instrumentation and 1 hour ofbaseline measurements, the subjects 
received a primed continuous infusion of crystalline insulin (Actrapid 
HM, Novo Industri S/A) at a rate of 6 pmol/kg per minute (1 mU/kg per 
minute) for 2 hours. Euglycemia was maintained by deterrnining plasma 
glucose concentration every 5 minutes and periodically adjusting a 
variable infusion of 20% dextrose.6 Hypokalemia was prevented by 
administration of KCI infused at a rate of 3 mmol/h. Hemodynarnic 
measurements were recorded for 5 minutes every 15 minutes throughout 
the study. Blood samples were collected every 30 minutes for analysis 
of substrate and hormone concentrations. 
To demonstrate the efficacy of thoracic sympathectomy, we 
measured blood pressure and limb blood flow responses to 2 minutes 
of immersion of the hand in ice water (cold pressor test) and 
compared vasoconstrictor responses in the denervated and innervated 
limbs during the second minute of this test. V asoconstrictor re-
sponses to immersion of the hand in ice water in the sympathetically 
denervated forearm were abolished; during the second minute of the 
cold pressor test, vascular resistance had increased by 48±20% in 
the innervated limb, whereas it had decreased by 17±5% in the 
denervated limb (P<0.02 innervated versus denervated limbs). 
To document that differential blood flow responses to insulin/ 
glucose infusion in the forearm and the calf were related specifically 
to sympathetic denervation (rather than to differential responses of 
forearm and calf blood flow to insulin infusion), we also studied 3 
patients who had undergone bath thoracic and lumbar sympathecto-
my (3 men; mean±SE age, 35±7 years; body mass index, 23.5±1.7 
kg/m2) and 4 contra! subjects (4 men; mean±SE age, 24±1 years; 
body mass index, 22.7±0.6 kg/m2). 
Protocol 2: Hyperinsulinemic Euglycemic Clamp 
Performed During Concomitant Systemic 
L-NMMA Infusion 
Six of the 9 subjects (2 men and 4 women; mean±SE age, 38±5 years; 
body mass index, 21.4±1.0 kg/m2) returned for this protocol. The protocol 
was identical ta protocol 1, except that during the second 30 minutes of 
baseline and during the entire 2-hour clamp, the subjects received (in 
randornized order) either a concomitant systemic L-NMMA infusion (50 
µ,g/kg per minute) or a vehicle (normal saline) infusion. To demonstrate that 
the L-NMMA-induced hemodynarnic effects plateau at the time the clamp 
was commenced, in 10 healthy subjects we infused L-NMMA at the same 
rate over 60 minutes. We found that mean arterial pressure increased 
significantly (P<0.01) from 77±2 mm Hg at baseline to 84±2 mm Hg 
after 30 minutes of infusion and then remained unchanged at 86±2 and 
85±2 mm Hg after45 and 60minutes of infusion, respectively (P>O.l, 30 
versus 60 minutes). In 4 of these subjects, the L-NMMA infusion was 
continued for a total of 150 minutes, and, in accordance with data by 
Dijkhorst-Oei and Koomans,7 arterial pressure did not increase any further 
(88±3 and 90±4 mm Hg at 60 and 150 minutes, respectively; P>O.l). 
Consistent with previous findings, 8 limb blood flow and vascular resistance 
remained unchanged; values for forearm blood flow at baseline and after 60 
minutes of infusion were 2.76±0.18 and 2.77±0.19 mIJlOO mL per 
minute, respectively, and those for vascular resistance were 29.0± 1.6 and 
33.0±2.8 U, respectively. In the 4 subjects in whom the infusion was 
continued for a total of 150 minutes, forearm blood flow (2.43±0.30 versus 
2.52±0.20 mLJmin per 100 mL) and vascular resistance (36.3±4.9 versus 
37.1 U) did not change between 60 and 150 minutes of infusion. 
To examine whether the L-NMMA-induced hemodynamic effects 
were related specifically to NO synthase inhibition, at the end of the 
2-hour clamp, insulin/glucose infusion was continued for another 30 
minutes, whereas the L-NMMA infusion was replaced by L-arginine 
(50 mg/kg over 10 minutes). Hemodynamic measurements were 
repeated' 15 minutes after the end of L-arginine infusion. 
TABLE 1. Effects of a 2-Hour lnsulin/Glucose Infusion on 
Plasma Glucose, lnsulin, and Potassium Concentrations, Mean 
Arterial Pressure, Limb Blood Flow, and Vascular Resistance 
Variable 
Glucose, mmol/l 
lnsulin, mU/l 
Potassium, mmol/l 
Forearm blood flow, ml (1 OO ml · min) 
Forearm vascular resistance, U 
Calf blood flow, ml (100 ml· min) 
Calf vascular resistance, U 
Baseline 
5.1±0.1 
8.4±1.0 
3.6±0.1 
2.15±0.22 
46.8±4.0 
1.94±0.26 
55.8±7.4 
Mean arterial pressure, mm Hg 93 ± 3 
Entries are for 9 subjects. Data are given as mean±SE. 
* P<0.05 vs baseline. 
Analytical Methods 
Clamp 
5.1 ±0.1 
86.4±4.9* 
3.6±0.1 
2.95±0.32* 
34,2±3.5* 
2.52±0.32* 
41.9±5.5* 
91±4 
Plasma glucose was determined in duplicate by the glucose oxidase 
method on a Beckman glucose analyzer (Beckman Instruments). 
Plasma insulin was measured by radioimmunoassay.2 
Data Analysis 
Mean arterial pressure was calculated as diastolic pressure plus one 
third pulse pressure. Limb vascular resistance was calculated as 
mean arterial pressure in millimeters of mercury divided by blood 
flow in milliliters per minute per 100 mL tissue, expressed in units. 
The 5 minutes of data from forearm and calf blood flow, blood 
pressure, and heart rate collected every 15 minutes were averaged to 
a single value. Whole body glucose uptake was assumed to be equal 
to exogenous glucose infusion necessary to maintain euglycemia 
during the clamp2 and was averaged for 30-minute periods. Statis-
tical analysis was performed by ANOV A for repeated measures 
followed by Fisher's post hoc test. For single comparisons, the 
2-tailed paired t test or the Wilcoxon signed rank test was used, as 
appropriate. A P value <0.05 was considered statistically signifi-
cant. Data are given as mean±SE. 
Results 
Protocol 1 
During the 2-hour euglycemic hyperinsulinemic clamp, muscle 
blood :flow increased (and vascular resistance decreased) in bath 
the denervated forearm and the innervated calf (Table 1 ). The 
increase in muscle blood :flow was comparable in magnitude (at 
the end of the clamp, blood :flow had increased by 37±5% and 
32±6% and vascular resistance had decreased by 28±3% and 
by 24±3% in the forearm and the calf, respectively) but was 
markedly different in time course. In the denervated forearm, 
almost all of the vasodilation occurred within the first 30 minutes 
of insulin infusion, whereas in the innervated calf, insulin-
induced stimulation of muscle blood :flow was progressive and 
occurred mainly during the second hour of the clamp (P<0.02, 
forearm versus calf) (Figure 1). 
In the 3 subjects who had undergone bath lumbar and 
thoracic sympathectomy, >80% of the insulin-induced vaso-
dilation in the denervated calf occurred within the first 30 
minutes, and the time course was virtually superimposable to 
the one observed in their denervated forearm (and to the one 
observed in the denervated forearm of the subjects who had 
undergone thoracic sympathectomy alone ). In the 4 control 
subjects, as expected, the insulin-induced vasodilation in the 
innervated forearm and calf was slower in onset compared 
588 Hypertension October 1999 
40 
-~ 0 
s 
:s: 
0 
ii:: 20 
"O 
0 
0 
Cii 
0 
15 45 75 105 
0 
-15 
-30 
15 45 75 105 
Time (minutes) 
Figure 1. Mean±SE blood flow and vascular resistance 
responses to a 2-hour insulin/glucose infusion in the sympathet-
ically denervated forearm (0) and the innervated calf (Il) in 9 
subjects. The insulin-induced vasodilator response occurred sig-
nificantly more rapidly in the denervated than in the innervated 
limb. 
with the one observed in the patients with denervated limbs, 
and blood :flow continued to increase progressively through-
out the clamp. Blood :flow values at time 0, 30, 60, 90, and 
120 minutes of the hyperinsulinemic clamp in the innervated 
forearm were 2.0±0.2, 2.5±0.4, 3.0±0.3, 3.3±0.4, and 
3.6±0.4 mL/min per 100 mL and in the innervated calf were 
2.0±0.2, 2.6±0.6, 2.9±0.7, 3.1±0.7, and 3.3±1.0 mL/min 
per 100 mL, respectively. 
Forearm Vascular 
Resistance 
(8%) 
Mean Arterial 
Pressure 
(mmHg) 
Whole Body Glucose 
Uptake 
(mg/kg/min) 
Figure 2. Mean±SE effects in 9 subjects of a 2-hour insulin/ 
glucose infusion performed during concomitant saline (Il) or 
L-NMMA (0) infusion on forearm vascular resistance, mean ar-
terial pressure, and whole body glucose uptake. *P<0.05 vs 
saline infusion. 
Protocol 2 
L-NMMA infusion did not have any detectable effect on 
plasma glucose and insulin concentrations at baseline and 
during the insulin/glucose infusion (Table 2). 
L-NMMA infusion significantly (P<0.05) increased baseline 
mean arterial pressure and markedly altered the blood pressure 
and forearm blood :flow responses to insulin/glucose infusion 
(Table 2). While mean arterial pressure remained unchanged 
during the clamp plus vehicle infusion, it increased significantly 
when the clamp was performed during concomitant L-NMMA 
infusion (Table 2). In the denervated forearm, L-NMMA infu-
sion attenuated the insulin-induced vasodilation. At the end of 
the clamp, forearm blood :flow had increased by 30±6% during 
vehicle infusion but by only 10±5% during L-NMMA infusion, 
whereas the forearm vascular resistance had decreased by 
19±5% during vehicle infusion but remained unchanged 
(-1 ±4%) during L-NMMA infusion (Figure 2). When, at the 
end of clamp, L-NMMA infusion was replaced by L-arginine 
infusion, the altered hemodynamic responses to insulin were 
restored. Mean arterial pressure decreased from 104±5 to 
95 ±5 mm Hg (P<0.01 ), and forearm blood :flow increased from 
2.37±0.23 to 2.73±0.33 mL/100 mL per minute (P=0.07). 
In contrast to these marked hemodynamic actions, 
L-NMMA did not have any detectable effect on whole body 
glucose uptake. During the last 30 minutes of the clamp, 
whole body glucose uptake was 7.3±0.6 and 7.5±1.2 mg/kg 
per minute during vehicle and L-NMMA infusion, respec-
tively (Figure 2). 
TABLE 2. Comparative Effects of a 2-Hour lnsulin/Glucose Infusion, Performed Alone or With Concomitant 
L-NMMA Infusion, on Plasma Glucose, lnsulin, and Potassium Concentrations, Mean Arterial Pressure, Limb 
Blood Flow, and Vascu!ar Resistance 
l-NMMA 
Variable Baseline Clamp Baseline Al one Clamp+L-NMMA 
Glucose, mmol/l 5.0±0.1 5.0±0.1 4.9±0.1 4,9±0.1 5.0±0.1 
lnsulin, mU/l 7.7±0.9 77.1 ±3.8* 6.1 ±1.5 6.0±1.0 76.3±5.8t 
Potassium, mmol/l 3.8±0.1 3.6±0.1 3.8±0.1 3.6±0.1 
Forearm blood flow, ml (100 ml · min) 2.05±0.13 2.66±0.18* 2.17±0.21 2.15±0.22 2.37±0.23 
Forearm vascular resistance, U 45.4±4.4 36.3±3.3* 43.3±5.7 47.7±6.2 46.7±6.3 
Mean arterial pressure, mm Hg 91±5 94±5 90±7 96±6 104±5t 
Entries are for 6 subjects. Data are given as mean±SE. 
*P<0.05, clamp vs baseline. 
tP<0.05, clamp+L-NMMA vs l-NMMA alone. 
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Discussion infusion impairs insulin-stimulated glucose uptake. 15 In con-
It is now clear that insulin exerts cardiovascular effects by stimu- trast, the present findings suggest that in humans, a clinically 
lating NO release, but the underlying mechanisms are not known.1 relevant impairment in NO release (as evidenced by the 
Here we provide the first evidence that insulin stimulates muscle increase in baseline arterial pressure) does not alter insulin 
blood flow in sympathectomired limbs by a direct action at the stimulation of glucose uptake. 
vasculature in vivo. In healthy subjects having undergone regional In summary, we have used an experimental model (region-
thoracic sympathectomy forhyperhidrosis, a2-hourinsulininfusioll!:;,,.i:: al sympathectomy) to study vascular actions of insulin in the 
increased muscle blood flow in the denervated forearm by roughly' :::<.(,.presence and absence of sympathetic vasodilator and vaso-
40%, an increase that was of comparable magnitude to the ori~' (;::'. · constrictor innervation in humans. We found that insulin has 
observed in the innervated calf. · ·' a direèt vasodilator action in the skeletal muscle vasculature 
The experimental model of regional sympathectomy not 
only allowed us to study the potential contribution of sym-
pathetic vasodilator (nitrergic) nerves to insulin vasodilation, 
but also permitted us to examine whether sympathetic vaso-
constrictor tone modulates such vasodilation. In innervated 
limbs, as in the present study, insulin-induced vasodilation 
consistently has been found to be slow in onset and to occur 
progressively.1 In contrast, in the denervated forearm vaso-
dilation rapidly reached its maximum (during the first 30 to 
45 minutes of insulin infusion) and remained stable thereaf-
ter. This finding is specific for denervation and not related to 
differential vasodilator responses to insulin infusion in the 
forearm and the calf, as evidenced by the studies in the 
patients who had undergone both lumbar and thoracic sym-
pathectomy and in the control subjects. Consistent with the 
rapid onset of the vasodilation in sympathetically denervated 
limbs in vivo, insulin rapidly stimulates NO release in 
cultured human vascular endothelial cells9 and in vascular 
ring preparations in vitro.10 
Previous findings indicated that prevention of the insulin-
induced sympathetic activation by dexamethasone abolishes 
the stimulation of muscle blood flow during insulin infusion 
in humans. 11 Taken together with the present findings, these 
earlier findings suggest that the baseline sympathetic vaso-
constrictor tone prevents the direct vasodilator action of 
insulin in innervated limbs, because it can only be demon-
strated in the absence (surgical sympathectomy), but not in 
the presence (dexamethasone studies), of sympathetic inner-
vation. Consistent with this hypothesis, in patients with 
autonomie failure (sympathetic denervation as an experiment 
of nature), insulin infusion evokes vasodilation and hypoten-
sion.' Second, in innervated limbs, stimulation, by insulin, of 
sympathetic vasodilator outflow is necessary to induce vaso-
dilation, because the suppression of the insulin-induced 
sympathetic activation also abolishes the vasodilation. 
To examine whether NO contributes to the direct local 
vasodilator action of insulin, we examined the effects of 
systemic inhibition of NO synthase by L-NMMA infusion on 
insulin-induced stimulation of blood flow in sympathecto-
mized limbs. We found that L-NMMA infusion markedly 
attenuated the insulin-induced stimulation of muscle blood 
flow and decrease in vascular resistance in sympathectomized 
limbs. This effect was related specifically to NO synthase 
inhibition, as evidenced by the L-arginine studies. 
Insulin resistance is a common feature of essential hyper-
tension, 12·13 and preliminary evidence suggests that endothe-
lial dysfunction may contribute to impaired muscle glucose 
uptake. 14 In rats, arterial hypertension induced by L-NMMA 
in vivo. This direct vasodilator action is mediated by stimu-
lation of NO release and appears to be masked by the 
sympathetic vasoconstrictor tone in innervated limbs. 
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